Macrophage Polarization States in the Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
The M1/M2 macrophage paradigm plays a key role in tumor progression. M1 macrophages are historically regarded as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis. The tumor microenvironment (TME) can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes. Investigating TME-induced macrophage polarization is critical for further understanding of TAM-related pro-tumor outcomes and potential development of new therapeutic approaches. This review explores the current understanding of TME-induced macrophage polarization and the role of M2-polarized macrophages in promoting tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21,22,23].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs express high levels of both iNOS and arginase-1, which both play a direct role in suppression of T-cell function [95].”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Inflammation can be triggered by conditions such as infection or injury or can be systemic as seen in type 2 diabetes and cardiovascular disease [59].”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 3×
“Current literature supports the theory that most TAMs originate from either tissueresident embryonic macrophages or macrophages derived from circulating monocytes that originate in the bone marrow [87].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 3×
“The significance of macrophage heterogeneity has been under review since the early 2000s and has been linked to many malignancies and autoimmune disorders in recent years [66].”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“The resolution of inflammation is led by the deactivation of these inflammatory mediators, permitting either the apoptosis of pro-inflammatory M1 macrophages or the transition to an anti-inflammatory M2 macrophage [64].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 15×
“Macrophages are found in every human tissue in the body and exhibit anatomical and functional diversity [4].”
BackgroundInfluentialMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · cited 2×
“Some noncytokine, extrinsic pathways of macrophage polarization do exist, however, including hypoxia as well as the production of lactate within tumors, which drive M2 polarization [36].”
BackgroundFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Cited by
Items 201–300 of 1,000
Wang, L., Shen, K., Gao, Z., Ren, M., Wei, C., Yang, Y., Li, Y., Zhu, Y., Zhang, S., Ding, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202304991 · Cited by 40
Advances in Melanoma: From Genetic Insights to Therapeutic Innovations
Valdez-Salazar, F., Rio, L. A. J.-D., Padilla‐Gutiérrez, J. R., Valle, Y., Muñóz-Valle, J. F., & Valdés‐Alvarado, E. (2024) · Biomedicines · doi:10.3390/biomedicines12081851 · Cited by 40
“…beneficial or harmful roles in the body: M1-like macrophages, “fighter” macrophages, in the immune response produce pro-inflammatory cytokines like IL-12 and TNF-α and generate reactive oxygen species (ROS) that attack tumor cells, promoting antitumor immunity and inhibiting tumor growth [88,89].”
BackgroundOncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways
Jaiswal, A., Shrivastav, S., Kushwaha, H. R., Chaturvedi, R., & Singh, R. P. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01818-0 · Cited by 37
“Ultimately, this immune cell activation, including M2-like responses, cultivates an immunosuppressive milieu facilitating the tumor growth and likely contributing to cancer progression in COVID-19 [135].”
BackgroundHarnessing myeloid cells in cancer
Park, S., Pylaeva, E., Bhuria, V., Gambardella, A. R., Schiavoni, G., Mougiakakos, D., Kim, S.-H., & Jabłońska, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02249-2 · Cited by 40
“Also, recruited macrophages derived from circulating monocytes are widely considered to be tumor suppressor cells, while tissue-resident macrophages are regarded as a target of cancer therapy [106–108].”
Zhou, X., Wang, X., Sun, Q., Zhang, W., Liu, C., Ma, W., & Sun, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113096 · Cited by 39
SENP1‐KLF4 signalling regulates LPS ‐induced macrophage M1 polarization
Wang, K., Xiong, J., Lu, Y., Wang, L., & Tian, T. (2023) · The FEBS Journal · doi:10.1111/febs.16589 · Cited by 35
Wu, X., Lü, W., Xu, C., Jiang, C., Zhuo, Z., Wang, R., Zhang, D., Cui, Y., Chang, L., Zuo, X., et al. (2023) · Journal of Immunology Research · doi:10.1155/2023/6455704 · Cited by 39
TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress
Zhu, K., Su, F., Yang, J., Xiao, R., Wu, R.-Y., Cao, M.-Y., Ling, X., & Zhang, T. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09097-7 · Cited by 42
“M1-like TAMs are primarily activated by IFN-γ, transforming growth factor-α (TGF-α) or granulocyte–macrophage [55].”
BackgroundThe dance of macrophage death: the interplay between the inevitable and the microenvironment
Makuch, M., Stepanechko, M., & Bzowska, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1330461 · Cited by 38
“These macrophages are more frequently found in TME than M1-like type and correlate with poor prognosis (200).”
BackgroundInfluentialJang, Y., Cho, Y. S., Kim, A., Zhou, X., Kim, Y., Wan, Z., Moon, J. J., & Park, H. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c18569 · Cited by 34
Su, G.-L., Peng, Y., Ruan, H., Cheng, J., Deng, T., & Zhang, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101863 · Cited by 44
“[212,213] However, during the terminal stages of inflammation or under the stimulation of specific signals, macrophages may shift towards the anti-inflammatory M2 phenotype.”
Rana, P. S., Soler, D. C., Kort, J., & Driscoll, J. J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1059715 · Cited by 37
“Macrophages are polarized towards an M2 phenotype with anti-inflammatory and immune suppressive functions (Boutilier and Elsawa, 2021).”
BackgroundKariagina, A., & Doseff, A. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415753 · Cited by 39
“Cancer cells produce IL-10, CCL2, and VEGF that induce M2 macrophage polarization, promoting tumor immune evasion [89].”
BackgroundXiong, Y., Li, N., Han, M., Ye, F., Liu, T., Ye, H., Zheng, T.-T., Wu, J.-J., Li, Y., Lv, S., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124110 · Cited by 35
Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells
Ebeling, S., Kowalczyk, A., Pérez-Vázquez, D., & Mattiola, I. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1171794 · Cited by 39
“Notably, both markers were originally linked to a M2-like profile and therefore a tumorpromoting phenotype (67).”
BackgroundWei, F., Fang, R., Lyu, K., Liao, J., Long, Y., Yang, J., Wen, W., & Sun, W. (2023) · Oral Oncology · doi:10.1016/j.oraloncology.2023.106532 · Cited by 35
Liang, Y., Wu, J., Yan, Y., Wang, Y., Zhao, H., Wang, X., Chang, S., & Li, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189779 · Cited by 34
“M2-like M2-like macrophages play a role in angiogenesis, immune suppression, and promoting metastasis in the TME [119].”
BackgroundMitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy
Ahn, M., Ali, A., & Seo, J. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1453886 · Cited by 39
Recent Developments in Glioblastoma‐On‐A‐Chip for Advanced Drug Screening Applications
Maity, S., Bhuyan, T., Jewell, C., Kawakita, S., Sharma, S., Nguyen, H. T., Najafabadi, A. H., Ermis, M., Falcone, N., Chen, J., et al. (2024) · Small · doi:10.1002/smll.202405511 · Cited by 34
Unraveling the role of M2 TAMs in ovarian cancer dynamics: a systematic review
Wang, Y.-P., Ma, C., Li, X., Yang, F., Wang, N., Ji, G., Liu, Q., Zhu, H., Xu, S., & Li, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06643-8 · Cited by 36
M1 macrophages – unexpected contribution to tumor progression
Kovaleva, O. V., Rashidova, M. A., Sinyov, V. V., Malashenko, O. S., & Gratchev, A. N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1638102 · Cited by 37
“Current research continues to explore macrophage reprogramming strategies, aiming to convert pro-tumoral M2 macrophages back into anti-tumoral M1 types, thus enhancing the overall effectiveness of anti-cancer therapies (67).”
Kruglov, O., Vats, K., Soman, V., Tyurin, V. A., Tyurina, Y. Y., Wang, J., Williams, L., Zhang, J., Carey, C. D., Jaklitsch, E. L., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2192098 · Cited by 33
Hsu, S., Chou, C., Lin, I., Chang, W., Kuo, I., & Chiu, C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01633-7 · Cited by 39
Zhao, H., Huang, M., & Jiang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216149 · Cited by 34
“M1 macrophages can be differentiated by LPS, IFN-γ , and CSF2 stimulation [27], while M2 macrophages can be differentiated by IL-4, IL-13, TGF-β , TNF-α , and glucocorticoids [26,28–30].”
BackgroundHu, Z., You, L.-Y., Hu, S., Yu, L., Gao, Y., Li, L., & Zhang, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111149 · Cited by 36
Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases
Jiang, S., Yang, H., & Li, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512524 · Cited by 35
“M1 macrophages oppose tumor cells and sustain the inflammatory response by secreting nitric oxide (NO), producing pro-inflammatory cytokines, and activating immune cell responses [94].”
BackgroundSun, Y., Jiang, G., Wu, Q., Ye, L., & Li, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1213347 · Cited by 33
“M1-like macrophages are mainly polarized by interferon (IFN-g ) (29) produced by TH1 cells and type 1 immune response, lipopolysaccharide (LPS) produced by bacteria, granulocyte-macrophage colony-stimulating factor (GM-CSF) (30)and tumor necrosis factor (TNF), mainly TNF - a induces polarization…”
BackgroundYin, C., Li, J., Li, S., Xi, Y., Lu, Y., Wang, C., & Liu, B. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.111031 · Cited by 34
Kment, J. L., Newsted, D., Young, S., Vermeulen, M., Laight, B. J., Greer, P. A., Lan, Y., & Craig, A. W. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02677-9 · Cited by 34
Malik, S., Sureka, N., Ahuja, S., Aden, D., Zaheer, S., & Zaheer, S. (2024) · Cell Biology International · doi:10.1002/cbin.12226 · Cited by 35
“This contributes to their role in antitumor immunity and resistance against pathogen invasion (Boutilier & Elsawa, 2021; Chen, Jin, et al., 2021; Feng et al., 2022; Han et al., 2021; Shu et al., 2020).”
InfluentialLiu, H., Lv, Z., Zhang, G., Yan, Z., Bai, S., Dong, D. F., & Wang, K. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03164-y · Cited by 35
“Conversely, M0 TAMs are activated into M2 TAMs by IL-4, IL-10, IL-13, CSF-1, corticosteroids, and other factors [17, 19], including certain immune cells, specific genetic oncogenes, and lactic acid-rich hypoxic conditions that promote M2 TAM polarization through different mechanisms [20, 21].”
BackgroundPark, M. N., Kim, M., Lee, S., Kang, S., Ahn, C., Tallei, T. E., Kim, W., & Kim, B. (2025) · Antioxidants · doi:10.3390/antiox14050501 · Cited by 42
“The NOX1–ROS–exosome axis, in particular, has emerged as a key mechanism driving M2 macrophage polarization, CD8 + T cell suppression, and angiogenesis in the TME [164].”
Yu, Y. W., Huang, Y., Li, C., Ou, S., Xu, C., & Kang, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1047004 · Cited by 31
TME-targeted approaches of brain metastases and its clinical therapeutic evidence
Khan, I. M., Khan, S. U., Sala, H. S. S., Khan, M. U., Din, M. A. U., Khan, S., Hassan, S. S. U., Khan, N. M., & Liu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1131874 · Cited by 31
“In the LM animal model, CSF infiltrates many macrophages and releases proinflammatory factors IL-6 and TNF, which act on tumor cells and up-regulate the highaffinity iron transport system LCN2/SLC22A17 to “hijack” rare iron elements in themicroenvironment and reduce the phagocytic function of macrophages (85).”
BackgroundWei, Q., Liu, G., Huang, Z., Huang, Y., Huang, L., Huang, Z., Wu, X., Wei, H., & Pu, J. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s408800 · Cited by 32
“In TME, macrophages can be converted into two subtypes, M1-type and M2-type macrophages.(41) M1-type macrophages are responsible for pro-inflammatory cytokine production and secretion, which are always activated by Th1 cytokines LPS and IFN-γ.”
BackgroundLi, Y.-R., Ochoa, C. J., Zhu, Y., Kramer, A. B., Wilson, M., Fang, Y., Chen, Y., Singh, T., DiBernardo, G., Zhu, E., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107952 · Cited by 35
FBXO38 regulates macrophage polarization to control the development of cancer and colitis
Zheng, X., Jiang, Q., Han, M., Ye, F., Wang, M., Qiu, Y., Wang, J., Gao, M., Hou, F., & Wang, H. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01081-2 · Cited by 32
Wang, Y., Li, T., Wang, F., Yao, X., Bai, Q., Su, H.-W., Li, J., Li, W., & Tan, R. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.104404 · Cited by 33
Singer, M., Zhang, Z., Dayyani, F., Zhang, Z., Yaghmai, V., Choi, A., Valerin, J. B., Imagawa, D. K., & Abi‐Jaoudeh, N. (2024) · Cancers · doi:10.3390/cancers17010066 · Cited by 35
“M2 macrophages strongly express TIGIT, which reduces the release of TNF-α , IL-β , and IL-12, inhibiting macrophage-induced cytotoxicity [114].”
Wang, Q., Sun, Z., Guo, J., Li, H., Zhang, J., Zhang, B., Zhou, B., & Feng, Y. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217596 · Cited by 34
Advances in the interrelated nature of vaginal microecology, HPV infection, and cervical lesions
Cui, M., Wu, Y., Liu, Z., Liu, Y., & Fan, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1608195 · Cited by 35
“The distinction between M1 and M2 macrophages oversimpli fi es the intricate polarization process, which involves dynamic interactions between multiple cytokines, chemokines, and neighboring cells (Boutilier and Elsawa, 2021).”
Wu, H., Li, J., Yao, R., Liu, J., Su, L., & You, W. (2025) · Theranostics · doi:10.7150/thno.113727 · Cited by 36
“M2 macrophages express high levels of CD163, stabilin-1, CD206, CD301, detin-1 and CD209 [39, 47].”
InfluentialChen, X., Jiang, J., Liu, H., Li, A., Wang, W., Ni, Z., & Lin, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109217 · Cited by 35
Gazzillo, A., Polidoro, M. A., Soldani, C., Franceschini, B., Lleò, A., & Donadon, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416197 · Cited by 33
“Therefore, TAMs with different morphologies and molecular fingerprints coexist in CLMs and correlate with clinicopathological variables [112].”
BackgroundInfluentialZhan, C., Jin, Y. H., Xu, X., Shao, J., & Jin, C. (2023) · Cancer Medicine · doi:10.1002/cam4.5489 · Cited by 33
Zeng, Y., Song, G., Zhang, S., Li, S., Meng, T., Yuan, H., & Hu, F. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00523 · Cited by 30
Understanding cervical cancer at single-cell resolution
Yue, S., Wang, Q., Zhang, J., Hu, Q., & Liu, C. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216408 · Cited by 32
Xue, L., Wang, C., Qian, Y., Zhu, W., Liu, L., Yang, X., Zhang, S., & Luo, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111196 · Cited by 31
Wu, H., Ma, T., He, M., Xie, W., Wang, X., Lu, L., Wang, H., & Cui, Y. (2024) · Phytotherapy Research · doi:10.1002/ptr.8146 · Cited by 31
“Within the TME, macrophages, especially the M2-polarised subtype, commonly referred to as tumour-associated macrophages (TAMs), have emerged as key players in promoting tumour growth and metastasis (Boutilier & Elsawa, 2021).”
BackgroundTransmissible ER stress between macrophages and tumor cells configures tumor microenvironment
Wei, W., Zhang, Y., Song, Q., Zhang, Q., Zhang, X., Liu, X., Wu, Z., Xu, X., Xu, Y., Yan, Y., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04413-z · Cited by 30
“Hypoxia, lactate production and other cytokines can shift macrophage polarization from an anti-tumor M1-like phenotype towards a pro-tumor M2-like based on the environmental changes in the TME [45].”
BackgroundLin, L., Du, Y., Hao, J., WU, R. T., & Du, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114322 · Cited by 30
Function of TRP channels in monocytes/macrophages
Wu, J., Li, Z., Deng, Y., Lu, X., Luo, C., Mu, X., Zhang, T., Liu, Q., Tang, S., Li, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1187890 · Cited by 39
Wang, X., Ye, X., Chen, Y., & Lin, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110848 · Cited by 31
Kare, A. J., Nichols, L. A., Zermeno, R., Raie, M. N., Tumbale, S. K., & Ferrara, K. W. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24788 · Cited by 29
“…is crucial for tumor response and often studied using the “ classically activated, pro-inflammatory M1 ” and “ alternatively activated, anti-inflammatory, wound-healing M2 ” paradigm [115, 116] (although this definition has now been revised to reflect a spectrum of fluid states [117, 118]).”
BackgroundYang, H., Lei, Z., He, J., Zhang, L., Lai, T., Liu, Z., Wang, N., Tang, Z., Sui, J.-D., & Wu, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05118-6 · Cited by 32
“M1 macrophages are considered pro-inflammatory and play a role in inhibiting tumor growth, whereas M2 macrophages exhibit anti-inflammatory functions and are known to promote tumor progression [11, 12].”
BackgroundReprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment
Kim, S. W., Kim, C. W., Moon, Y.-A., & Kim, H. S. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2336249 · Cited by 31
“Moreover, because of plasticity, the polarization state of macrophages is not fixed and can change based on the integration of multiple signals from the TME (Bardi et al. 2018; Boutilier and Elsawa 2021; Laviron et al. 2022).”
Inorganic Nanoparticle Functionalization Strategies in Immunotherapeutic Applications
Mao, W., & Yoo, H. S. (2024) · Biomaterials Research · doi:10.34133/bmr.0086 · Cited by 33
“They can be polarized into 2 basic phenotypes under different stimulations: M1-type macrophage (M1) and M2-type macrophage (M2), which are also referred to as TAM [142,143].”
BackgroundGe, Y., Zhou, Q., Pan, F., & Wang, R. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s505539 · Cited by 30
Traditional Chinese medicine in the treatment of breast Cancer
Song, P., Liu, T., Zhang, Y., Shao, T., Li, R., Chen, A., Cao, L.-Q., Chen, Z., Guo, W., & Duan, D. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02416-5 · Cited by 31
Wang, D., Wang, F., Kong, X., Li, Q., Shi, H., Zhao, S., Li, W., Li, Y., & Meng, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113376 · Cited by 33
PD‑L1 mediates triple‑negative breast cancer evolution via the regulation of TAM/M2 polarization
Meng, Z., Zhang, R., Wu, X., Zhang, M., & Jin, T. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5440 · Cited by 29
“TAMs are a key component of the TME (34).”
Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
Wu, Z., Ou, J., Liu, N., Wang, Z., Chen, J., Cai, Z., Liu, X., Yu, X., Dai, M., & Zhou, H. (2022) · Cancer Medicine · doi:10.1002/cam4.5549 · Cited by 30
Ge, W., & Wu, W. (2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.106.07 · Cited by 39
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
Wang, S., Wang, H., Li, C., Liu, B., He, S., & Tu, C. (2024) · MedComm · doi:10.1002/mco2.489 · Cited by 40
“192 While anti-CD47 promotes phagocytosis of tumor cells by macrophages, 193 it also promotes transformation to TAMs phenotype, 194 which produces cytokines that inhibit CD8 + T cells and activate Tregs.”
BackgroundChen, C., Zhou, S., Yang, X., Ren, M., Qi, Y., Mao, Y., & Yang, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116657 · Cited by 31
Obesity modulates the immune macroenvironment associated with breast cancer development
Núñez-Ruiz, A., Sánchez-Brena, F., López-Pacheco, C. P., Acevedo-Dominguez, N. A., & Soldevila, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266827 · Cited by 27
“Accordingly, the M1/M2 ratio was significantly decreased (Fig 4G), indicating that obesity may promote an enhanced immunosuppressive milieu that has been described to favor tumor growth [53].”
BackgroundZhou, W.-H., Wang, Y., Yan, C., Du, W., Al-Aroomi, M., Zheng, L., Lin, S., Gao, J.-X., Jiang, S., Wang, Z.-X., et al. (2022) · Discover Oncology · doi:10.1007/s12672-022-00533-x · Cited by 23
“A diverse array of signals generated from tumor cells could profoundly and differentially influence the polarization of TAMs [21].”
BackgroundTao, J., Yang, P., Gao, M., Zhang, F., Wu, Y., Jiang, Y. J., Ning, Y., Li, Z., & Ai, F. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100622 · Cited by 30
Mahmoudian, R. A., Akhlaghipour, I., Lotfi, M., Shahidsales, S., & Moghbeli, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154472 · Cited by 29
Histotripsy induces apoptosis and reduces hypoxia in a neuroblastoma xenograft model
Iwanicki, I. J., Wu, L. L., Flores-Guzmán, F., Sundland, R. M., Viza-Gomes, P., Nordgren, R. K., Centner, C. S., Kandel, J. J., Applebaum, M. A., Bader, K. B., et al. (2023) · International Journal of Hyperthermia · doi:10.1080/02656736.2023.2222941 · Cited by 29
“Given that this study utilized nude mice lacking mature T cells, TNF a upregulation suggests a shift in macrophage polarization to anti-tumor activity after histo-tripsy [35,36].”
Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment
Masel, R. H., Roche, M. E., & Martinez‐Outschoorn, U. (2023) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2023.101514 · Cited by 28
Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development
Thapa, K., Khan, H., Kaur, G., Kumar, P., & Singh, T. G. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149130 · Cited by 31
Adenosine, bridging chronic inflammation and tumor growth
Chen, L., Alabdullah, M., & Mahnke, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258637 · Cited by 33
“The polarization of TAMs, controlled by cancer cells, is not fi xed to distinct M1 or M2 subpopulations, but a rather hybrid activation state of pro-and anti-in fl ammatory phenotype that can be found in developing cancers (28).”
BackgroundCholinergic Polarization of Human Macrophages
Roa-Vidal, N., Rodríguez-Aponte, A. S., Lasalde‐Dominicci, J. A., Capó-Vélez, C. M., & Delgado‐Vélez, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115732 · Cited by 27
“These TAM-type cells can exhibit phenotypes akin to M1 macrophages [22] and M2 macrophages [23].”
BackgroundLim, S.-K., Lin, W.-C., Huang, S., Pan, Y., Hu, C.-W., Mou, C., Hu, C. J., & Mou, Y. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-023-00022-w · Cited by 27
“…bacteria can polarize macrophages toward the anti-tumor M1 subtype as well as prime antigen-presenting cells (APCs) for enhanced functionality of T-cell co-stimulation or cross presentation (Boutilier and Elsawa, 2021), thereby tipping the differential selective pressure against cancer cells.”
Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization
Choi, J. Y., Seok, H. J., Lee, D. H., Lee, E., Kim, T., Bae, S., Shin, I., & Bae, I. H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01570-5 · Cited by 30
“M2 macrophages contribute to accelerate cell proliferation, angiogenesis, tissue repair, and metastasis through various anti-inflammatory mechanisms [44, 45].”
BackgroundHypoxia-Driven Changes in Tumor Microenvironment: Insights into Exosome-Mediated Cell Interactions
Wang, C., Xu, S., & Yang, X. J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s479533 · Cited by 30
Tan, S., Tang, H., Wang, Y., Xie, P., Li, H., Zhang, Z., & Zhou, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19296 · Cited by 26
“The polarized phenotype can be identified by macrophage markers [19].”
BackgroundYang, B. L., Wang, X.-X., Wei, X., & Ma, J. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002944 · Cited by 28
“Given that monocytes/macrophages have multiple plasticity phenotypes, [21–23] such as classically activated (M1) and alternatively activated (M2), we further analyzed the phenotype of CAR-THP1.”
BackgroundYu, M., Yu, H., Wang, H., Xu, X., Sun, Z., Chen, W., Yu, M., Liu, C., Jiang, M., & Zhang, X. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5688 · Cited by 29
“M2 macrophages exert complex immunomodula‑ tory functions depending on these cytokines, which possess cancer‑promoting and inflammation‑inhibiting effects by trig‑ gering immunosuppression (12).”
BackgroundRole of N6‐methyladenosine RNA modification in cancer
Qu, Y., Gao, N., Zhang, S., Gao, L., He, B., Wang, C., Gong, C., Shi, Q., Li, Z., Yang, S., et al. (2024) · MedComm · doi:10.1002/mco2.715 · Cited by 31
Tumor-Infiltrating Immune Cells in Colorectal Cancer
Ferkel, S. A. M., Holman, E. A., Sojwal, R. S., Rubin, S. J. S., & Rogalla, S. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101091 · Cited by 32
Badran, O., Cohen, I., & Bar‐Sela, G. (2024) · Cancers · doi:10.3390/cancers16244156 · Cited by 31
Zhang, R., Tan, Y., Xu, K., Huang, N., Wang, J., Liu, M., & Wang, L. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03683-4 · Cited by 27
“M2 macrophages induce hypoxia and suppress the immune system, [117] while neutrophils secrete chemokine ligands that mediate the infiltration of M2 macrophages and regulatory T cells, reshaping the TME to suppress the immune response [118].”
The lactylation-macrophage interplay: implications for gastrointestinal disease therapeutics
Che, X., Zhang, Y., Chen, X., Xie, G., Li, J., Xu, C., Zhang, C., Zhu, Y., & Yang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1608115 · Cited by 34
“They play a role in preventing excessive in fl ammation and promoting tissue repair (68, 72 – 74).”
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
Yang, H., Liu, D., Qiu, L., Wang, R., Zhang, C., Yu, D., Zhong, Q., Yuki, N., Song, Z., Zhu, Τ., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02459-8 · Cited by 38
Understanding the complexity of tumor-associated macrophages: Druggable and therapeutic insights
Li, A.-Q., Huang, F., Talaiti, S., Yang, X. Y., Bi, H., & Fang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.021 · Cited by 31
“Macrophages or monocytes are recruited into tumor tissues by CSF-1, CCL2, and CXCL12 and become TAMs under stimulation of tumor cells or TME 3,172 — 175 .”
The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
Zhang, Z., Liu, F., Chen, W., Liao, Z., Zhang, B., Zhang, B., Liang, H., Chu, L., & Zhang, Z. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00281-2 · Cited by 29
“In general, M1 macrophages mediate tissue damage induced by reactive oxygen species, and are helpful in antimicrobial and antitumor activities [43, 49]; M2 macrophages are involved in Th2 cell involved immune response and inflammatory suppression, and promote tissue remodeling, angiogenesis, tumor formation and progre…”
BackgroundGori, M., Giannitelli, S. M., Vadalà, G., Papalia, R., Zollo, L., Sanchez, M., Trombetta, M., Rainer, A., Pino, G. D., & Denaro, V. (2022) · Molecules · doi:10.3390/molecules27103126 · Cited by 30
“5 × 104/cm2 THP-1 cells were cultured onto the two surfaces for 24 h with and without stimulation with lipopolysaccharide (LPS) and human recombinant gamma-interferon (IFN-γ), inducing their polarization to M1 pro-inflammatory macrophages [54,55,57].”
MethodThe remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment
Zhong, J., GUO, J., ZHANG, X., FENG, S., Di, W., WANG, Y., & ZHU, H. (2022) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.027900 · Cited by 31
Chen, J.-L., Tai, Y.-S., Tsai, H.-Y., Hsieh, C.-Y., Chen, C., Liu, C., Wu, D., Huang, Y., & Lin, M. (2023) · Molecules · doi:10.3390/molecules28041725 · Cited by 28
“To promote cancer cell proliferation, metastasis, and chemoresistance, cancer cells induce macrophage M2 phenotype polarization in the tumor microenvironment [8,9].”
BackgroundWang, X., Bai, Y., Zhang, F., Li, D., Chen, K., Wu, R., Tang, Y., Wei, X., & Han, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.955949 · Cited by 33
“M2-polarized macrophages are contributors to play a role in pro-tumor and anti-inflammation activity (79), which may be the underlying reason for the poor prognosis in BLCA patients with high COL10A1 expression.”
BackgroundZhu, X., Xu, Y., Wang, J., Xue, Z., Qiu, T., & Chen, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1165602 · Cited by 27
“However, the molecular signaling underlying this interactive regulation is known to be a complicated and dynamic process but is not well described (21).”
BackgroundYou, G., Zheng, Z., Huang, Y., Liu, G., Luo, W., Huang, J., Zhuo, L., Tang, B., Liu, S., & Lin, C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14269 · Cited by 27
“43 According to expression of differential genes, the sub - groups of malignant cells were annotated as follows: (1) the MES-like malignant cells with high expression of VIM; (2) the OPC-like malig - nant cells characterized with high OLIG1, ALCAM and PLP1 expres - sion; (3) the NPC-like malignant cells highly express…”
MethodmRNA vaccine in gastrointestinal tumors: Immunomodulatory effects and immunotherapy
Zhang, A., Ji, Q., Sheng, X., & Wu, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115361 · Cited by 27
Li, Z., Guo, M., Lin, W., & Huang, P. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102897 · Cited by 27
Macrophage lncRNAs in cancer development: Long-awaited therapeutic targets
Arab, I., Park, J., Shin, J.-J., Shin, H., Suk, K., & Lee, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115890 · Cited by 27
Single-cell RNA sequencing in melanoma: what have we learned so far?
Lim, S. Y., & Rizos, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104969 · Cited by 29
Landscape of exosomes to modified exosomes: a state of the art in cancer therapy
Mirgh, D., Sonar, S., Ghosh, S., Adhikari, M. D., Subramaniyan, V., Gorai, S., & Anand, K. (2024) · RSC Advances · doi:10.1039/d4ra04512b · Cited by 28
Niu, L., Wang, Q., Feng, F., Yang, W., Xie, Z., Zheng, G., Zhou, W., Duan, L., Du, K., Li, Y., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166917 · Cited by 26
Metadata
- Authors
- Boutilier, A. J., & Elsawa, S. F.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- Elsawa, Sherine F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 6995
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8268869
- OpenAlex
- W3173665490
- Cited by
- 1,631
- References
- 148
- Citations by year
- 2026: 281 · 2025: 409 · 2024: 429 · 2023: 359 · 2022: 144 · 2021: 9
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P20 GM113131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- macrophage polarization, tumor-associated macrophages, tumor microenvironment, tumor progression, angiogenesis, lymphangiogenesis, immunosuppression, hypoxia, metastasis, macrophage recruitment
- MeSH terms
- Tumor-Associated Macrophages, Animals, Hypoxia, Cell Transformation, Neoplastic, Humans, Inflammation, Macrophage Activation, Neoplasm Metastasis, Neoplasm Staging, Signal Transduction, Biomarkers, Immunophenotyping, Cytokines, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.